Nasdaq:US$32.32 (+0.02) | HKEX:HK$50.30 (-0.50) | AIM:£4.72 (+0.04)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Other Ventures | 19 Apr 2010

Seven-year extension of IP protection for Chi-Med’s main prescription drug

1 items
a100419